Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-21

Clinical Trial Update: Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a mixture of liposomal bupivacaine and bupivacaine for transversus abdominis plane (TAP) block in open hysterectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liposomal bupivacaine + bupivacaine mixture

Snippet

Sponsor: Henry Ford Health System | Conditions: Hysterectomy | Phase 4 | Status: COMPLETED | Results posted: 2022-12-21